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Data on enzyme activities and kinetics have often been reported with insufﬁcient experimental
detail to allow their repetition. This paper discusses the objectives and recommendations of
the Standards for Reporting Enzyme Data (STRENDA) project to deﬁne minimal experimental
standards for the reporting enzyme functional data.
& 2014 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY
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In any form of communication it important to understand
what others are talking about and in science it is essential
for data to be reported in a form that allows others to
repeat, verify and apply the determinations. Unfortunately,
that has not always the case with enzyme activity and
kinetic data, because insufﬁcient experimental details have
been provided. An idea of the nature of the difﬁculties can
be obtained from enzyme properties and kinetics databases,
such as BRENDA (http://www.brenda-enzymes.org) and
SABIO-RK (http://sabio.villa-bosch.de) (Schomburg et al.,
2014; Wittig et al., 2014). It is not uncommon to ﬁnd that
older values for activity were determined at ‘room tempera
ture’ or in phosphate buffer, pH 7.2, with no indication of
the buffer concentration or the counter ion used. Since
enzyme activities and kinetic properties are dependent on
the assay conditions (e.g., temperature, pH, ionic strength
and other system components) under which they are
determined, as well as on the nature of the system being
studied, it is essential that these data are fully documented
in any reports. Furthermore, the expression of enzyme
activities in ill-deﬁned or arbitrary units is not uncommon
and it is relatively rare to ﬁnd any meaningful statistical
estimation of the errors of all reported enzyme parameters.
The STRENDA commission
The Standards for Reporting Enzyme Data (STRENDA) commis-
sion (http://www.beilstein-institut.de/en/projects/strenda)
was set up in 2003, as a result of an initiative of the
Beilstein-Institut (http://www.beilstein-institut.de; Kettnerand Hicks, 2005; Apweiler et al., 2005), in order to address
these problems. A series of meetings on ‘Experimental
Standard Conditions of Enzyme Characterizations’ (ESCEC)
has been held at which experts discussed possibilities for
improvement of reporting enzyme data. Their conclusions
emphasised the urgent need for recommendations for the
standardisation of data reporting in this area, and that such
standards should be independent of the organism being
studied and intended application of the data. The task of
the STRENDA commission was to investigate how this could be
achieved. The present composition of the commission is listed
on its website (http://www.beilstein-institut.de/en/projects/
strenda), where the proceedings of the previous ESCEC meet
ings can also be found. Membership is open for additional
scientists willing to help in the work and input from the
scientiﬁc community is welcomed.
The objective of the STRENDA Commission is to provide a
framework for ensuring that enzyme functional data are
recorded with adequate detail of the assay conditions and
reliability. This aim is not to tell people how to assay
enzymes or what conditions they must use but simply to
ensure that they provide sufﬁcient information.
Basic information
It is relatively easy to think about what one might need to
know from any paper reporting enzyme activities. Some of
the obvious questions are listed below:1. About the enzyme
(a) What was the enzyme assayed?
(b) What was the source? (species, tissue/organelle).
2.
3.
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(d) Had it been modiﬁed in any way? (e.g. fusion protein,
His-tagged, proteolysed, de-glycosylated etc.).
About the determination
(a) What was the reaction followed?
(b) What was the assay temperature?
(c) What buffer pH and concentration?
(d) What was the substrate concentration?
(e) What were the concentrations of any other sub-
strates necessary?
(f) How much enzyme was used in each assay?
(g) Were any activators/inhibitors/stabilisers present?
(h) What assay procedure was used and were initial
(linear) rates determined?
The results
(a) What was the enzyme activity obtained (with error
estimates)?
(b) Was the activity proportional to the enzyme
concentration?
(c) What are the units of the values reported?Most of these are self-evident and should not require further
explanation. It might not be thought of as asking too much of
those reporting enzyme activities to provide such data, but it is
quite common to ﬁnd some of this essential information missing
from publications. For example, the literature contains several
examples of statements of the type ‘the enzyme was assayed
by a modiﬁcation of the method of xy et al.’ without detailing
what the modiﬁcations were. The full composition and pH of
the assay mixture is required.
For identifying the enzyme studied, the EC number and
accepted name, which can be found through the ExplorEnz
website (http://www.enzyme-explorer.org), together with
its source should be adequate but, since EC classiﬁcation is
functional system that is based on the reaction catalysed
rather than the structure or location of the enzyme, it may
also be necessary to identify a speciﬁc isoenzyme. Several
alternative names, which are sometimes ambiguous or
misleading, have been used for the same enzyme in many
cases, but these may generally be related to the EC number
and accepted name by searching ExplorEnz.
There is no recommendation as to which substrate(s) should
be used for assays, but it is important that they are identiﬁed
and their concentrations speciﬁed. Confusion can arise in, the
names used for substrates, with different names being used for
the same compound. IUPAC names (Panico et al., 1994) should
be unambiguous but these are sometimes too cumbersome for
routine use. The CAS (Chemical Abstracts Service) number of
the compound should allow its identiﬁcation through the free
Common Chemistry utility (http://www.commonchemistry.
org). Alternatively several databases provide alternative
names that have been used for individual compounds together
with their IUPAC names (http://pubchem.ncbi.nlm.nih.gov/;
http://www.chemspider.com/; http://www.ebi.ac.uk/chebi/;
http://www.genome.jp/kegg/). A common problem with com
pounds that exist in more than one isomeric form is the failure
to indicate which form was used.
The question of whether the enzyme under study has been
modiﬁed in any way is important since such modiﬁcations
may affect its behaviour. It is common to ﬁnd that proteo-
lysed preparations are used, either by design or accident,
with the assumption that if the enzyme preparation hasactivity, it must be satisfactory. However, there is a con-
siderable amount of evidence that this may not be a valid
assumption. Proteolytic cleavage can occur quite easily
during extraction and puriﬁcation of enzymes and this is,
for example, known to affect the pH optimum of fructose
bisphosphatase (EC 3.1.3.11) as well as the allosteric proper-
ties of that enzyme (Nimmo and Tipton, 1982) and of
glutamate dehydrogenase [NAD(P)+] (EC 1.4.1.3) (McCarthy
and Tipton, 1985). Despite this, an increasing number of
studies have been conducted with preparations that are
truncated, fused with another protein, contain tags, such
as poly-His, lack native glycosylation or are suspended in
some unusual detergent without any investigation as to
whether these have altered the behaviour of the enzyme..
The units in which enzyme activities are given should be
speciﬁed, but their form has not been standardized. Activities
are generally expressed as the amount product formed in unit
time per amount enzyme protein present. This is often known
as the International unit (IU) when 1 IU is the amount of
enzyme that produces 1 mmol of product per min. The SI
equivalent of the IU is the katal (mol/s) and this may
alternatively be used as a unit of activity (conversion factors
1 IU=16.67 nkat; 1 kat=6 107 IU). This is the recommended
unit of the International Federation of Clinical Chemistry and
Laboratory Medicine (IFCC) and the International Union of
Pure and Applied Chemistry (IUPAC) (Dybkaer, 2001). How-
ever, many biochemists ﬁnd this an inconveniently small unit
of activity and continue to use the IU (see also Bisswanger,
2014). It is also common to ﬁnd enzyme activities expressed
in non-standard units, such as the amount of enzyme
catalysing a speciﬁed change in absorbance within a speciﬁc
time (s, min or h). Since these are often referred to as units,
there is scope for confusion with the IU.
The stoichiometry of the reaction assayed is also of
importance in this context. For example, the enzyme
carbamoyl-phosphate synthase (ammonia) (EC 6.3.4.16)
catalyses the reaction
2 ATPþNH3þCO2þH2O¼ 2 ADPþphosphate
þcarbamoyl phosphate
and so the activity expressed in terms of disappearance of
ATP or formation of ADP would be twice that obtained if any
of the other substrates or products were measured. Simi-
larly, the NAD(P)H-dependent nitric-oxide synthase (EC
1.14.13.165) catalyses
2 L-arginineþ3 NADðPÞHþ3 Hþ þ4 O2 ¼ 2 L-citrulline
þ2 nitric oxideþ3 NADðPÞþ þ4 H2O
Thus, it is important to specify reaction studied and the
substrate or product measured when expressing activity of
an enzyme.
Expression of enzyme activity in this way assumes that the
initial velocity is proportional to the enzyme concentration.
Although that is usually the case, there are cases where it is
not (Dixon et al., 1979; McDonald and Tipton, 2002) and so it
is always important to check. Similarly it is important to
measure the initial rate of the reaction catalysed. With the
increased use of high-throughput assays, in which the amount
of product formed (or substrate used) is determined after
some ﬁxed time, it is, of course, necessary to ensure that the
values obtained do, indeed, represent initial velocities.
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closely controlled conditions for assaying speciﬁc enzymes of
diagnostic relevance so that values can be related between
laboratories and to ‘normal’ ranges. The IFCC has produced
“several primary reference procedures” for the assay of such
enzymes (see, e.g. Schumann et al., 2011), which provide
complete assay details. Other researchers have a greater
freedom to select assay conditions that they ﬁnd convenient.
Several manufacturers produce test kits for speciﬁc enzymes,
although it is not always easy to ﬁnd their exact composition.
More-speciﬁc information
The list discussed above might be sufﬁcient if one's only
interest was to compare enzyme activities between labora-
tories, individuals, species or tissues. However, additional
information may be necessary for other types of work. The
Km value(s) could be important to help one chose the assay
substrate concentrations and the maximum velocity (V)
might help in deciding how much enzyme to use. The
complete kinetic parameters might be needed for systems
biology or mechanistic studies. In that case it would also be
of value to know how the kinetic parameters were deter-
mined and the error estimates associated with each value.
So far the list of requirements has avoided telling researchers
what to do. For example, the method that was used determin-
ing the Km and V (or kcat) values is requested, together with the
range of substrate concentrations used, without any guidance
on whether there is any preferred procedure. Double-reciprocal
(Lineweaver–Burk) plots continue to be widely used, despite
this being well-known to be the least accurate of the proce-
dures used (Dowd and Riggs, 1965), but it is judged better to
have the information available than to censor any that may be
less reliable. Error estimates (standard errors, standard devia-
tions or conﬁdence limits) should be provided for each value
reported.
In the case of enzymes that show apparently cooperative
kinetics, the substrate concentration that gives half-maximum
velocity (S0.5) and some measure of the cooperativity is also
required. Hill coefﬁcient (h or nH) is the most widely used of




which will be 81 for a system following simple Michaelis–
Menten kinetics and approximately 811/h for a cooperative
system, is an acceptable alternative. Note that although the
symbol n continues to be often used for the Hill coefﬁcient it
invites confusion with the number of binding sites.
Inhibitors
Much research is now concentrated on enzyme inhibition,
because of its great importance for drug development. This
necessitates the provision of additional information, which
will depend on the type of inhibition. For all types of
inhibition it is important to show whether the inhibition is
reversible by removal of excess inhibitor, for example by
dilution or dialysis of the enzyme-inhibitor mixture, and
whether the inhibition increases with the time that the
enzyme is incubated with the inhibitor.For simple reversible inhibitors, the substrate and inhibitor
concentration ranges used in the study should be provided in
addition to the Ki values and types of inhibition observed. The
concentrations of any other required substrates are necessary
since the Ki value will be dependent on these for most reaction
mechanisms. It is also possible to ﬁnd cases of partial inhibition
where an excess of inhibitor does not completely prevent the
reaction from occurring. These are, fortunately, quite rare and
their treatment has been discussed in detail elsewhere (Dixon
et al., 1979; Tipton, 1996). Similar considerations apply, of
course, to data for activators, with the important difference
that there may be some activity in the absence of activator.
Some inhibitors have such high afﬁnities for the enzyme that
the concentrations required for inhibition are comparable to
those of the enzyme. Such tight-binding inhibitors, where the Ki
is similar to the enzyme concentration, pose speciﬁc problems,
because the binding of the inhibitor to the enzyme will
signiﬁcantly reduce the free inhibitor concentration and so
the assumption that the total inhibitor concentration is equal to
the free inhibitor concentration, which is implicit in the usual
treatments of reversible inhibition, is no longer valid. The rates
of development of inhibition and recovery of activity after
removal of the excess inhibitor may also be relatively slow.
Speciﬁc graphical and computer-based procedures are available
for determining the kinetic parameters and the type of
inhibition (Williams and Morrison, 1979; Szedlacsek and
Duggleby, 1995).
In the case of irreversible inhibitors it is important to
know whether inhibition is time-dependent, and if so how
long enzyme and inhibitor were incubated together before
the activity was determined. The different types of irrever-
sible inhibition and their kinetic behaviour have been
discussed in detail elsewhere (McDonald and Tipton, 2012).
In many instances IC50 (or I50) values are reported. These are
simply deﬁned as the amount of inhibitor that gives a 50%
decrease in activity. For reversible inhibitors these have little
meaning unless one knows the type of inhibition and the
substrate concentrations. The relationships between IC50 Ki
and Km values and substrate concentrations for the different
types of inhibition have been reported (Dixon et al., 1979;
McDonald and Tipton, 2002). For irreversible, time-dependent
inhibitors the value will depend on the time for which the
enzyme was pre-incubated with inhibitor before assay. In the
presence of excess inhibitor one would expect the IC50 to
approach a value of half the enzyme concentration as the pre-
incubation time is increased.
Such considerations mean that the use of IC50 values
should be discouraged, indeed, many authors have been
discouraging their use for over half a century, but the fact
remains that tables of such values continue to appear in the
literature (especially in the pharmacological literature)
posing the dilemma as to whether to include them.Forms and checklists
Few people enjoy ﬁlling out forms. In fact some would prefer a
visit to the dentist to having to do so. Nevertheless, it is
important to collect the data in tabular form if they are to be
made easily accessible and also to provide checklists for
authors, and journals to ensure that the necessary data have
been provided. A problem is that although it is relatively easy
135STRENDA and STRENDA Consortiumto list what data one would like to have, it becomes more
convoluted and quasi-legalistic when put on a form in terms of
information ﬁelds to be completed. The nastier and more
complicated the form, the more the resistance one might
expect from the user. The design of such a data deposition form
has been a major preoccupation of the STRENDA Commission
and it has undergone many revisions before the current on-line
form that is that is planned to be released in the ﬁrst half of
2014. Currently, on the STRENDA website a prototype of the
productive version is provided for further comments and
suggestions for improvement (http://www.beilstein-institut.
de/en/projects/strenda; Apweiler et al., 2010).
Over 30 international journals (listed on the STRENDA
website) have, so far, encouraged adherence to the
STRENDA guidelines and it is hoped those working in the
ﬁeld will see the advantage of following them in reporting
their own data. It is not the function of the STRENDA
Commission to force scientists to use the form before their
data can be published, rather it is to be hoped that they will
come to appreciate the value of doing so.
Dissemination
As well as collecting information, it is important to make it
readily and freely accessible to everyone who may want to
use it. That involves creating a database. This can be a real
service because it is often difﬁcult and time-consuming to
ﬁnd such data from the literature. Naturally, it is reasonable
to ask whether we need yet another database. There are
many databases that duplicate each other, with each
claiming to offer some advantage over those already extant,
although the only apparent advantage often appears to be
that of allowing the publication of yet another database
paper. Enzyme activity and kinetic data can be found
elsewhere (http://www.brenda-enzymes.org; http://
sabio.villa-bosch.de/), but the uniqueness of this approach
is that it intends to provide the data together with the
conditions under which they were determined to allow
others to duplicate or apply it. Furthermore, the data
should be in a form that can be freely used by other
databases and incorporated into them in whole or in part.
Extensions
Biochemists may have different reasons for determining
enzyme data. Industrial enzymologists may be particularly
interested in behaviour at elevated temperatures, whereas
ease of assay may be a prime concern of others. This may
involve using non-physiological substrates, working under
conditions far removed from those occurring within the cell
or adding ‘unnatural’ components to the assay mixture.
Systems biologists would like the data to be collected under
standard conditions that approximate to those pertaining in
the tissue, cell or organelle they wish to model. However,
even a brief survey of the literature will indicate that this
has been far from the case. Even with what is apparently
the same enzyme, different laboratories often assay under
different conditions and the assay conditions used for
different enzymes in the same metabolic pathway can differ
markedly. Some attempts have been made to formulate
recommendations about assay conditions (Dixon et al.,1979), but these are somewhat imprecise and of little
relevance to physiological conditions.
Originally many studies were conducted at ‘room tem-
perature’, which could, of course, vary widely between
laboratories. It was then recommended that enzymes should
be assayed at 25 1C, which was, at that time, regarded as a
standard ‘room temperature’. However, not all laboratories
were able to meet this requirement and the standard assay
temperature was raised to 30 1C. Even this gradual thermal
inﬂation does not satisfy those studying human enzymes,
who would regard a temperature of 37 1C as being closer to
that in most tissues and conditions. However, this deﬁnition
of physiological temperature for a mammalian system would
not be appropriate, for example, to thermophilic bacteria
or poikilotherms.
The recommended that the assay pH should “where
practicable, be optimal” (Dixon et al., 1979). Is also not
very helpful, since the optimum pH may depend on the
choice of substrate, the substrate concentrations, buffer,
temperature and ionic strength and there are no strict
recommendations for any of these. Furthermore the opti-
mum pH may be far removed from the pH at which an
enzyme is perceived to operate in vivo. For example, the
optimum pH for arginase (EC 3.5.3.1) is reported to be
about pH 10 in horse, pH 9.8 in rat and pH 11 in Bacillus
brevis. Those working with mammalian systems might
favour an assay pH of about 7.2 which is believed to be
around the physiological pH within the cell, but clearly this
would be unphysiological for gastrointestinal enzymes,
such, as pepsin and trypsin, or for lysosomal enzymes.
Furthermore, the oxidation of ethanol by liver alcohol
dehydrogenase (EC 1.1.1.1) is often followed at higher pH
values because the equilibrium of the reaction greatly
favours ethanol formation at neutral pH.
Naturally it would be appropriate to use physiological
substrates for enzyme assays. However, many studies have
used unphysiological substrates for ease of manipulation
and assay. For example acetylthiocholine is frequently used
to assay acetylcholinesterase (EC 3.1.1.7) because the
thiocholine produced can be readily detected by reaction
with sulfydryl reagent 5, 50-dithiobis-2-nitrobenzoate (Nbs2)
releasing a yellow coloured compound whose formation can
be followed spectrophotometrically at 412 nm (Ellman
et al., 1961). Other examples include the use of 4-
nitrophenyl phosphate to assay alkaline phosphatase (EC
3.1.3.1) (Schumann et al., 2011). The use of synthetic
dyes as electron acceptors in oxidoreductase assays
has been common and in some cases the physiological
acceptor remains unknown. The demand for higher assay
sensitivity and high-throughput procedures has resulted in
the development of an increasing number of chromogenic
and ﬂuorogenic substrates (Goddard and Reymond, 2004;
Reymond et al., 2009). Clearly, in such cases a considerable
amount of work would be necessary to show whether the
enzyme behaves identically towards such substrates as it
does towards its physiological substrates.
It is often recommended that saturating substrate concen-
trations should be used (i.e. 410Km, for all substrates), as
discussed by Bisswanger (2014). This, of course, assumes that
the Km values have already been determined, at least
approximately. Furthermore, this might not always be practic-
able because of factors such as solubility, the occurrence of
K.F. Tipton et al.136high-substrate inhibition or a high absorbance of the assay
mixture affecting the behaviour of optical assays (Dixon et al.,
1979; McDonald and Tipton, 2002). It should also be remem-
bered that any change in the assay conditions (e.g., pH,
temperature, ionic strength) may affect the Km values.
The buffers and ionic strengths and used in enzyme assays
vary widely and are often far from physiological. It might be
helpful if it were possible to recommend a simple standard
buffer for use in all enzyme assays. Unfortunately, this goal
appears to be unobtainable, because at least some enzymes are
unhappy in one or other of the common buffers (see e.g., Boyce
et al., 2004). Furthermore, buffers that contain physiologically
occurring compounds can be problematical in that they are
likely to be substrates or inhibitors of for some other enzymes.
Several enzymes are sensitive to inhibition by high ionic
strengths and altering the concentrations of charged substrates
and the pH of the buffer may also affect this. The ionic strength
of assay media is seldom stated, although this can be calculated
if the full composition and pH of the assay mixture is given, it
would be helpful if all authors were required to state the value.
Other additives such as chelating or reducing compounds, which
are needed for the activity of some enzymes, will inhibit others
and speciﬁc metabolites are required to activate some
enzymes, such as acetyl Co-A for pyruvate carboxylase (EC
6.4.1.1) and N-acetyl-L-glutamate for carbamoyl-phosphate
synthase (ammonia) (EC 6.3.4.16).
Various attempts have been made to deﬁne assay media that
are appropriate for determining the behaviour of enzymes
under “in vivo-like” conditions (van Eunen et al., 2010; Goel
et al., 2012). However, from the above examples, it should be
clear that it is unlikely that a universal buffer medium, suitable
for all enzymes in all tissues and organelles, will be found.
Indeed different conditions should apply to the same enzymes
from different sources. Individual standards will be required for
each organism, organ and organelle to be studied, bearing in
mind that these may not be constant under all metabolic
conditions. Perhaps the answer will lie in more complex
mixtures, including proteins as buffers, that more closely mimic
the, crowded, in vivo environments of groups of enzymes. In its
attempts at formulating more physiologically relevant assay
conditions the STRENDA Commission needs advice from those
working with speciﬁc systems.
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